Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Flamen

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Clinical Nuclear Medicine|April 26, 2020
Colon Adenocarcinoma Associated With Clostridium Septicum Endophthalmitis Detected on 18F-FDG PET/CTNicolas Plouznikoff, Carlos Artigas, Erwin Woff, et al.
Clinical Nuclear Medicine|July 6, 2019
Incidental Detection of a Radiation-Induced Soft-Tissue Sarcoma on 68Ga-PSMA PET/CT in a Patient Previously Treated for Prostate CancerNicolas Plouznikoff, Erwin Woff, Carlos Artigas, et al.
Clinical Nuclear Medicine|November 7, 2019
Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical ResponseNicolas Plouznikoff, Carlos Artigas, Spyridon Sideris, et al.
Nuclear Medicine and Biology|April 11, 2021
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell linesWendy Delbart, Ghanem E Ghanem, Ioannis Karfis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
Reducing loss of image quality because of the attenuation artifact in uncorrected PET whole-body imagesJohan Nuyts, Sigrid Stroobants, Patrick Dupont, et al.
Clinical Nuclear Medicine|March 21, 2017
Vertebral Hemangioma Mimicking Bone Metastasis in 68Ga-PSMA Ligand PET/CTCarlos Artigas, François-Xavier Otte, Marc Lemort, et al.
Head & Neck|October 22, 2014
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancerYassine Lalami, Camillo Garcia, Patrick Flamen, et al.
Clinical Nuclear Medicine|June 23, 2009
Progressive osteoblastic bone metastases in breast cancer negative on FDG-PETValérie Huyge, Camilo Garcia, Anja Vanderstappen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2016
Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2Geraldine Gebhart, Patrick Flamen, Elisabeth G E De Vries, et al.
International Journal of Surgery Case Reports|August 9, 2014
Surgical strategy in abnormally increased Fluorine-18 fluorodeoxyglucose uptake in an asymptomatic lower esophageal submucosal tumor - Report of a caseJohnny Haddad, Fikri Bouazza, Hassan Baraké, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Clinical Nuclear Medicine|April 26, 2020
Colon Adenocarcinoma Associated With Clostridium Septicum Endophthalmitis Detected on 18F-FDG PET/CTNicolas Plouznikoff, Carlos Artigas, Erwin Woff, et al.
Clinical Nuclear Medicine|July 6, 2019
Incidental Detection of a Radiation-Induced Soft-Tissue Sarcoma on 68Ga-PSMA PET/CT in a Patient Previously Treated for Prostate CancerNicolas Plouznikoff, Erwin Woff, Carlos Artigas, et al.
Clinical Nuclear Medicine|November 7, 2019
Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical ResponseNicolas Plouznikoff, Carlos Artigas, Spyridon Sideris, et al.
Nuclear Medicine and Biology|April 11, 2021
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell linesWendy Delbart, Ghanem E Ghanem, Ioannis Karfis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
Reducing loss of image quality because of the attenuation artifact in uncorrected PET whole-body imagesJohan Nuyts, Sigrid Stroobants, Patrick Dupont, et al.
Clinical Nuclear Medicine|March 21, 2017
Vertebral Hemangioma Mimicking Bone Metastasis in 68Ga-PSMA Ligand PET/CTCarlos Artigas, François-Xavier Otte, Marc Lemort, et al.
Head & Neck|October 22, 2014
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancerYassine Lalami, Camillo Garcia, Patrick Flamen, et al.
Clinical Nuclear Medicine|June 23, 2009
Progressive osteoblastic bone metastases in breast cancer negative on FDG-PETValérie Huyge, Camilo Garcia, Anja Vanderstappen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2016
Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2Geraldine Gebhart, Patrick Flamen, Elisabeth G E De Vries, et al.
International Journal of Surgery Case Reports|August 9, 2014
Surgical strategy in abnormally increased Fluorine-18 fluorodeoxyglucose uptake in an asymptomatic lower esophageal submucosal tumor - Report of a caseJohnny Haddad, Fikri Bouazza, Hassan Baraké, et al.
Pageof 13